Infervision

Infervision is a medical imaging AI company that builds deep-learning diagnostics for radiology, deployed across hundreds of hospitals worldwide.

Overview

Infervision (推想医疗) develops AI models that assist radiologists in reading CT, X-ray and other studies, with particular strength in thoracic imaging. Its products flag pulmonary nodules, lesions and signs of conditions such as stroke and pneumonia, then organize worklists so critical findings surface first. The company holds regulatory clearances in multiple markets including China, the EU and the United States. Hospitals use Infervision to manage growing imaging volumes without proportionally growing radiology headcount.

Key Features

• Deep-learning detection for pulmonary nodules and thoracic findings
• Stroke and emergency imaging triage modules
• Smart worklist prioritization for radiology departments
• Quantitative measurement and longitudinal follow-up tools
• Multi-market regulatory clearances (NMPA, CE, FDA)
• Integration with hospital PACS and imaging networks

Pricing

Infervision sells through hospital procurement and enterprise agreements, with pricing per module, per site or per study volume depending on the deployment.

Who Is It For

Radiology departments, imaging centers and public health networks that need AI reading assistance at scale, especially in high-volume thoracic imaging.

FAQ

Is Infervision free to use?

No. It is a regulated medical device product sold to healthcare institutions.

Does Infervision offer an API?

Yes. Infervision integrates with hospital imaging systems and supports standardized DICOM interfaces for partners.

How does Infervision compare to alternatives?

Its multi-market regulatory portfolio and focus on thoracic imaging give it an edge over single-market imaging AI vendors.

Practical Use Cases

Radiology departments run Infervision’s thoracic models on high-volume chest CT lists, surfacing suspected nodules for review and reducing reading fatigue. Emergency departments use stroke triage modules to route critical findings to specialists first. Imaging networks standardize AI-assisted reading across sites, and quality teams track detection metrics over time. Research partners validate algorithms on institutional cohorts for regulatory and clinical studies.

Limitations & Alternatives

AI assistance improves consistency but does not replace radiologist judgment, and performance must be validated per site and scanner. Coverage concentrates on thoracic and select emergency indications rather than full-body imaging. Shukun, Yizhi AI and international players like Aidoc compete across overlapping modules.

Integrations & Deployment

Infervision connects to hospital PACS through DICOM interfaces, processing studies and returning flagged findings to the radiology worklist. Deployments include validation on local scanners, regulatory paperwork per market and integration with reporting systems. Multi-site hospital groups standardize on shared configurations while allowing per-site thresholds. Cloud and on-premise options suit different data policies, and vendor implementation teams coordinate with hospital IT around bandwidth and study volumes. Performance monitoring continues post-launch with periodic accuracy reviews against radiologist reads.